'Nicotine-Like Chemicals In U.S. Vapes May Be More Potent Than Nicotine, FDA Says' - Reuters News
Portfolio Pulse from Benzinga Newsdesk
The FDA has raised concerns about synthetic nicotine analogues like 6-methyl nicotine, which may be more potent and addictive than traditional nicotine. These substances are not currently regulated under U.S. tobacco and vaping laws, allowing manufacturers to sell them without FDA authorization. Altria Group has highlighted the risks and urged the FDA to evaluate these compounds. Charlie's Holdings, which uses 6-methyl nicotine in its SPREE BAR vapes, is expanding its product line and targeting international markets.
May 29, 2024 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Charlie's Holdings, which uses 6-methyl nicotine in its SPREE BAR vapes, is expanding its product line and targeting international markets. The FDA's concerns may impact its U.S. operations.
Charlie's Holdings' use of 6-methyl nicotine in its products and the FDA's concerns about these substances could lead to regulatory challenges in the U.S. market. However, the company's international expansion may mitigate some of the negative impact.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 70
NEGATIVE IMPACT
Altria Group has highlighted the risks of synthetic nicotine analogues like 6-methyl nicotine and urged the FDA to evaluate these compounds. This could lead to increased regulatory scrutiny.
Altria Group's proactive stance on urging the FDA to evaluate synthetic nicotine analogues indicates potential regulatory changes that could impact the market. This could lead to increased scrutiny and potential restrictions, negatively affecting companies involved in synthetic nicotine products.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 80